Novel approaches to pulmonary fibrosis

Glenn Hearson
Jan 28, 2015
1 min read

Updated: Jun 10, 2019

Review of recent discoveries around the underlying pathophysiology of IPF which have stimulated the development of novel therapies and new methods for diagnosis and assessment of prognosis.

This review was published in Royal College of Physicians Clinical Medicine:

http://www.clinmed.rcpjournal.org/content/14/Suppl_6/s45.long

#ipfstudy

Recent Posts

See All

Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)

DYNamic assessment of multi-organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19 findings published

Excel in Science Undergraduate students win abstract presentations at national meetings for their presentations titled “Will you regret dumping your X? Sex as a biological variable in Asthma Genomics”